[1]Whitcroft K L, Altundag A, Balungwe P, et al. Position paper on olfactory dysfunction: 2023[J]. Rhinology, 2023, 61(33): 1-108.
[2]Von Bartheld C S, Hagen M M, Butowt R. Prevalence of chemosensory dysfunction in COVID-19 patients: a systematic review and meta-analysis reveals significant ethnic differences[J]. ACS Chem Neurosci, 2020, 11(19): 2944-2961.
[3]Boscolo-Rizzo P, Spinato G, Hopkins C, et al. Evaluating long-term smell or taste dysfunction in mildly symptomatic COVID-19 patients: a 3-year follow-up study[J]. Eur Arch Otorhinolaryngol, 2023, 280(12): 5625-5630.
[4]Devanand D P, Lee S, Luchsinger J A, et al. Comparison of brief olfactory and cognitive assessments to neuroimaging biomarkers in the prediction of cognitive decline and dementia in the MCSA cohort[J]. Alzheimers Dement, 2024, 20(12): 8346-8358.
[5]Yoo J H, Kim T S, Kim J S, et al. Subjective distress mediates the association between olfactory dysfunction duration and depression in post COVID 19 patients[J]. Sci Rep, 2025, 15(1): 22216.
[6]Stefanou M I, Palaiodimou L, Bakola E, et al. Neurological manifestations of long-COVID syndrome: a narrative review[J]. Ther Adv Chronic Dis, 2022, 13: 20406223221076890.
[7]樊冰倩, 游芳佳, 刘梦帆, 等. 病毒感染后嗅觉障碍和慢性鼻窦炎伴嗅觉障碍患者的焦虑抑郁状态及影响因素分析[J]. 中国耳鼻咽喉头颈外科, 2022, 29(6): 341-345.
[8]Yi J S, Hura N, Roxbury C R, et al. Magnetic resonance imaging findings among individuals with olfactory and cognitive impairment[J]. Laryngoscope, 2022, 132(1): 177-187.
[9]Oleszkiewicz A, Schriever V A, Croy I, et al. Updated sniffin sticks normative data based on an extended sample of 9139 subjects[J]. Eur Arch Otorhinolaryngol, 2019, 276(3): 719-728.
[10]Yom-Tov E, Lekkas D, Jacobson N C. Association of COVID19-induced anosmia and ageusia with depression and suicidal ideation[J]. J Affect Disord Rep, 2021, 5: 100156.
[11]Coelho D H, Reiter E R, Budd S G, et al. Quality of life and safety impact of COVID-19 associated smell and taste disturbances[J]. Am J Otolaryngol, 2021, 42(4): 103001.
[12]Simonini L, Frijia F, Ait Ali L, et al. A comprehensive review of COVID-19-related olfactory deficiency: unraveling associations with neurocognitive disorders and magnetic resonance imaging findings[J]. Diagnostics, 2024, 14(4): 359.
[13]Llana T, Mendez M, Garces-Arilla S, et al. Association between olfactory dysfunction and mood disturbances with objective and subjective cognitive deficits in long-COVID[J]. Front Psychol, 2023, 14: 1076743.
[14]Bochicchio V, Mezzalira S, Maldonato N M, et al. Olfactory-related quality of life impacts psychological distress in people with COVID-19: the affective implications of olfactory dysfunctions[J]. J Affect Disord, 2023, 323: 741-747.
[15]Liu D T, Prem B, Sharma G, et al. Depression symptoms and olfactory-related quality of life[J]. Laryngoscope, 2022, 132(9): 1829-1834.[16]Favero R, Hajrulla S, Bordin A, et al. Olfactory dysfunction in COVID-19 patients who do not report olfactory symptoms: a pilot study with some suggestions for dentists[J]. Int J Environ Res Public Health, 2022, 19(3): 1036.
[17]Dintica C S, Marseglia A, Rizzuto D, et al. Impaired olfaction is associated with cognitive decline and neurodegeneration in the brain[J]. Neurology, 2019, 92(7): e700-e709.
[18]Sato S, Imaeda T, Mugikura S, et al. Association of olfactory and cognitive function test scores with hippocampal and amygdalar grey matter volume: a cross-sectional study[J]. Sci Rep, 2024, 14(1): 19138.
[19]Tian Q, An Y, Kitner-Triolo M H, et al. Associations of olfaction with longitudinal trajectories of brain volumes and neuropsychological function in older adults[J]. Neurology, 2023, 100(9): e964-e974.
[20]Paolini M, Harrington Y, Colombo F, et al. Hippocampal and parahippocampal volume and function predict antidepressant response in patients with major depression: a multimodal neuroimaging study[J]. J Psychopharmacol, 2023, 37(11): 1070-1081.
|